| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.00 | $3.85 | $5.31 | $6.05 | $1.13 | $3.48 | $3.37 | $2.50 |
| EPS (Diluted) | $0.99 | $3.83 | $5.28 | $6.02 | $1.13 | $3.48 | $3.37 | $2.50 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $3.7B | $3.6B | $3.4B | $2.9B | $2.5B | $2.3B | $2.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.0B |
| Total Liabilities | $4.6B | $3.4B | $3.2B | $3.0B | $2.6B | $2.2B | $2.0B | $1.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $0.4B | $-0.0B | $-0.5B | $-0.4B | $-0.2B | $-0.2B | $-0.1B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.5B | $0.1B | $0.2B | $0.5B | $0.4B | $0.1B | $0.1B | $0.2B |